208 related articles for article (PubMed ID: 15533847)
1. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
[No Abstract] [Full Text] [Related]
2. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Marty FM; Cosimi LA; Baden LR
N Engl J Med; 2004 Feb; 350(9):950-2. PubMed ID: 14985500
[No Abstract] [Full Text] [Related]
3. Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
Philip A; Sivaprakasam P; Sagar TG; Ganesan P
J Pediatr Hematol Oncol; 2012 Jul; 34(5):406. PubMed ID: 22713708
[No Abstract] [Full Text] [Related]
4. Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Meyer M; Waldvogel S; Chalandon Y; Bongiovanni M; Pache JC; Van Delden C
Scand J Infect Dis; 2007; 39(8):731-3. PubMed ID: 17654353
[TBL] [Abstract][Full Text] [Related]
5. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
[TBL] [Abstract][Full Text] [Related]
6. Torsades de pointes associated with voriconazole use.
Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
[TBL] [Abstract][Full Text] [Related]
7. Adverse reactions to voriconazole.
Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
[TBL] [Abstract][Full Text] [Related]
8. Lupus erythematosus-like lesions by voriconazole in an infant with chronic granulomatous disease.
Gomez-Moyano E; Vera-Casaño A; Moreno-Perez D; Sanz-Trelles A; Crespo-Erchiga V
Pediatr Dermatol; 2010; 27(1):105-6. PubMed ID: 20199430
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole-associated phototoxicity.
Riahi RR; Cohen PR
Dermatol Online J; 2011 Feb; 17(2):15. PubMed ID: 21382298
[TBL] [Abstract][Full Text] [Related]
11. [Voriconazole-associated phototoxicity].
Serra Soler G; Delgado Sánchez O; Esteban Marcos E; Martínez-López I; Femenías Sureda M
Farm Hosp; 2006; 30(6):386-7. PubMed ID: 17298198
[No Abstract] [Full Text] [Related]
12. [Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
Kohno S; Ogawa K; Kurashima A; Niki Y; Maesaki S
Jpn J Antibiot; 2007 Dec; 60(6):321-34. PubMed ID: 18447204
[No Abstract] [Full Text] [Related]
13. [Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Shindo M; Sato K; Jimbo J; Hosoki T; Ikuta K; Sano A; Nishimura K; Torimoto Y; Kohgo Y
Rinsho Ketsueki; 2007 May; 48(5):412-7. PubMed ID: 17571588
[TBL] [Abstract][Full Text] [Related]
14. New treatment for invasive fungal sinusitis: three cases of chronic invasive fungal sinusitis treated with surgery and voriconazole.
Nakaya K; Oshima T; Kudo T; Aoyagi I; Katori Y; Ota J; Hidaka H; Oda K; Kobayashi T
Auris Nasus Larynx; 2010 Apr; 37(2):244-9. PubMed ID: 19553042
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
Pongas GN; Lewis RE; Samonis G; Kontoyiannis DP
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():93-7. PubMed ID: 19754766
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
Mouas H; Lutsar I; Dupont B; Fain O; Herbrecht R; Lescure FX; Lortholary O;
Clin Infect Dis; 2005 Apr; 40(8):1141-7. PubMed ID: 15791514
[TBL] [Abstract][Full Text] [Related]
17. Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy.
Curigliano G; Formica V; De Pas T; Spitaleri G; Pietri E; Fazio N; de Braud F; Goldhirsch A
Ann Oncol; 2006 Jul; 17(7):1174-5. PubMed ID: 16410362
[No Abstract] [Full Text] [Related]
18. Pseudoporphyria as a result of voriconazole use: a case report.
Dolan CK; Hall MA; Blazes DL; Norwood CW
Int J Dermatol; 2004 Oct; 43(10):768-71. PubMed ID: 15485539
[TBL] [Abstract][Full Text] [Related]
19. The safety of voriconazole.
Potoski BA; Brown J
Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
[No Abstract] [Full Text] [Related]
20. Voriconazole-associated myositis.
Shanmugam VK; Matsumoto C; Pien E; Rosen J; Kumar P; Whelton S; Steen V
J Clin Rheumatol; 2009 Oct; 15(7):350-3. PubMed ID: 20009971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]